| 30449325 |
Actionable Activating Oncogenic ERBB2/HER2 Transmembrane and Juxtamembrane Domain Mutations
Pahuja, KB,
Nguyen, TT,
Jaiswal, BS,
Prabhash, K,
Thaker, TM,
Senger, K,
Chaudhuri, S,
Kljavin, NM,
Antony, A,
Phalke, S,
Kumar, P,
Mravic, M,
Stawiski, EW,
Vargas, D,
Durinck, S,
Gupta, R,
Khanna-Gupta, A,
Trabucco, SE,
Sokol, ES,
Hartmaier, RJ,
Singh, A,
Chougule, A,
Trivedi, V,
Dutt, A,
Patil, V,
Joshi, A,
Noronha, V,
Ziai, J,
Banavali, SD,
Ramprasad, V,
DeGrado, WF,
Bueno, R,
Jura, N,
Seshagiri, S
|
Cancer Cell |
2018 |
| 24971884 |
Impact of ERBB2 mutations on in vitro sensitivity of bladder cancer to lapatinib
de Martino, M,
Zhuang, D,
Klatte, T,
Rieken, M,
Rouprêt, M,
Xylinas, E,
Clozel, T,
Krzywinski, M,
Elemento, O,
Shariat, SF
|
Cancer Biol. Ther. |
2014 |
| 23220880 |
Activating HER2 mutations in HER2 gene amplification negative breast cancer
Bose, R,
Kavuri, SM,
Searleman, AC,
Shen, W,
Shen, D,
Koboldt, DC,
Monsey, J,
Goel, N,
Aronson, AB,
Li, S,
Ma, CX,
Ding, L,
Mardis, ER,
Ellis, MJ
|
Cancer Discov |
2013 |
![ERBB2 R678Q [plasma membrane] icon](/icon/R-ICO-012683.svg){kind=icon}
